Clinical trials
Candidemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 7 |
| Astellas Pharma Inc | 5 |
| Scynexis, Inc. | 3 |
| T2 Biosystems | 3 |
| Basilea Pharmaceutica | 2 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Augusta University | 1 |
| Bristol-Myers Squibb | 1 |
| Daniel Benjamin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Candidemia | 33 |
| Candidiasis, Invasive | 16 |
| Candidiasis | 14 |
| Mycoses | 9 |
| Fungemia | 6 |
| Sepsis | 6 |
| Aspergillosis | 3 |
| Invasive Fungal Infections | 2 |
| Pathologic Processes | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
Trials
Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.